Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
SAU:4014's Debt-to-EBITDA is ranked worse than 72.4% of 471
companies
in the Medical Devices & Instruments industry
Industry Median: 1.63
vs SAU:4014: 3.29
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Scientific and Medical Equipment House Co Debt-to-EBITDA Related Terms
Scientific and Medical Equipment House Co Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scientific and Medical Equipment House Co Debt-to-EBITDA Chart
Scientific and Medical Equipment House Co Annual Data
SAU:4014 vs ISRG, BDX, RMD: Debt-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Scientific and Medical Equipment House Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scientific and Medical Equipment House Co Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Scientific and Medical Equipment House Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Scientific and Medical Equipment House Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Scientific and Medical Equipment House Co (SAU:4014) has a Debt-to-EBITDA of 2.73 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Scientific and Medical Equipment House Co. This is near median its historical median of 2.53. Over the past decade, Scientific and Medical Equipment House Co's Debt-to-EBITDA has ranged from 1.91 to 3.29. According to the industry distribution chart, Scientific and Medical Equipment House Co ranks #341 out of 471 companies in the Medical Devices & Instruments industry, placing it in the top 72.4%.
Is Scientific and Medical Equipment House Co's Debt-to-EBITDA too high?
Scientific and Medical Equipment House Co's current Debt-to-EBITDA of 2.73 is near median its 10-year median of 2.53. Over the past 10 years, this metric has ranged from a low of 1.91 to a high of 3.29. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.63. Scientific and Medical Equipment House Co's value of 2.73 is 67.5% above this industry median. Based on the distribution chart, Scientific and Medical Equipment House Co ranks #341 out of 471 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Scientific and Medical Equipment House Co has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Scientific and Medical Equipment House Co's Debt-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Scientific and Medical Equipment House Co ranks #341 out of 471 companies for Debt-to-EBITDA. This places Scientific and Medical Equipment House Co in the lower half of its industry. The industry median Debt-to-EBITDA is 1.63. Scientific and Medical Equipment House Co's value of 2.73 is 67.5% above this benchmark. Historically, Scientific and Medical Equipment House Co's own Debt-to-EBITDA has ranged from 1.91 to 3.29 over the past decade. While the company's 10-year median is 2.53 vs. the industry median of 1.63, Scientific and Medical Equipment House Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.63, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scientific and Medical Equipment House Co's current Debt-to-EBITDA of 2.73 is 67.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Scientific and Medical Equipment House Co. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scientific and Medical Equipment House Co's current Debt-to-EBITDA is 2.73, which is near median its own 10-year median of 2.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scientific and Medical Equipment House Co stock overvalued right now?
Based on GuruFocus' analysis, Scientific and Medical Equipment House Co (SAU:4014) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼44.55, compared to a current price of ﷼28.34 — trading 36.4% below its estimated fair value. The current Debt-to-EBITDA is 2.73, which is near median its 10-year median of 2.53 and 67.5% above the Medical Devices & Instruments industry median of 1.63. Scientific and Medical Equipment House Co's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Scientific and Medical Equipment House Co (SAU:4014), the current Debt-to-EBITDA is 2.73 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scientific and Medical Equipment House Co (SAU:4014) Overvalued in 2026?
Based on GuruFocus' analysis, Scientific and Medical Equipment House Co stock appears to be undervalued.
The current stock price of ﷼28.34 is trading 36.4% below its estimated GF Value™ of ﷼44.55.
GuruFocus considers Scientific and Medical Equipment House Co to be Significantly Undervalued.
Key valuation signals for SAU:4014:
Debt-to-EBITDA: 2.73 (near median its 10-year median of 2.53)
GF Value™: ﷼44.55 vs. price of ﷼28.34 (36.4% below fair value)
Industry Position: 67.5% above the Medical Devices & Instruments median (#341 of 471)
No single metric tells the full story. See the SAU:4014 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scientific and Medical Equipment House Co is engaged in general contracting of buildings, roads, bridges, electrical, electronic and mechanical works, dams, roads and bridges, maintaining, cleaning, managing and operating of medical centers, cities' cleanliness, maintaining and operating of industrial, water and sewage works, maintenance of scientific and medical equipment, wholesale and retail trade in medical, laboratorial and scientific equipment and its accessories, import and export services, and catering services. Its segments consist of Operation and maintenance; Medical equipment sales and post-sale maintenance services revenue; Construction segment; Meat and Food segment; and and medical supplies segment.
81GF Score
Get the complete analysis for SAU:4014
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4014 has been successfully added to your 
